These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10502037)
1. Mossy fiber involvement in progressive supranuclear palsy. Arai K; Braak E; de Vos RA; Jansen Steur EN; Braak H Acta Neuropathol; 1999 Oct; 98(4):341-4. PubMed ID: 10502037 [TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
3. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Probst A; Langui D; Lautenschlager C; Ulrich J; Brion JP; Anderton BH Acta Neuropathol; 1988; 77(1):61-8. PubMed ID: 3149122 [TBL] [Abstract][Full Text] [Related]
4. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease. Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707 [TBL] [Abstract][Full Text] [Related]
5. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Togo T; Dickson DW Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627 [TBL] [Abstract][Full Text] [Related]
6. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. Zemaitaitis MO; Lee JM; Troncoso JC; Muma NA J Neuropathol Exp Neurol; 2000 Nov; 59(11):983-9. PubMed ID: 11089576 [TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344 [TBL] [Abstract][Full Text] [Related]
8. [Characterization of glial fibrillary tangles in progressive supranuclear palsy and Alzheimer's disease]. Nishimura M No To Shinkei; 1996 Oct; 48(10):895-903. PubMed ID: 8921528 [No Abstract] [Full Text] [Related]
9. Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Hanihara T; Amano N; Takahashi T; Nagatomo H; Yagashita S Neuropathol Appl Neurobiol; 1995 Aug; 21(4):319-26. PubMed ID: 7494600 [TBL] [Abstract][Full Text] [Related]
10. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy. Borghi R; Giliberto L; Assini A; Delacourte A; Perry G; Smith MA; Strocchi P; Zaccheo D; Tabaton M Neurology; 2002 Feb; 58(4):589-92. PubMed ID: 11865137 [TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles. Cruz-Sanchez FF; Rossi ML; Cardozo A; Deacon P; Tolosa E Neurosci Lett; 1992 Feb; 136(1):43-6. PubMed ID: 1321966 [TBL] [Abstract][Full Text] [Related]
12. A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy. Ishizawa K; Lin WL; Tiseo P; Honer WG; Davies P; Dickson DW J Neuropathol Exp Neurol; 2000 Jun; 59(6):513-24. PubMed ID: 10850864 [TBL] [Abstract][Full Text] [Related]
13. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy. Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815 [TBL] [Abstract][Full Text] [Related]
14. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Hauw JJ; Verny M; Delaère P; Cervera P; He Y; Duyckaerts C Neurosci Lett; 1990 Nov; 119(2):182-6. PubMed ID: 1704110 [TBL] [Abstract][Full Text] [Related]
15. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration. Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684 [TBL] [Abstract][Full Text] [Related]
17. [Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report]. Hanihara T; Kubota H; Amano N; Yamaoka K; Yagishita S No To Shinkei; 1994 May; 46(5):487-92. PubMed ID: 8060688 [TBL] [Abstract][Full Text] [Related]
18. Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy. Dugger BN; Tu M; Murray ME; Dickson DW Neurosci Lett; 2011 Mar; 491(2):122-6. PubMed ID: 21236314 [TBL] [Abstract][Full Text] [Related]
19. Neurofibrillary pathology in progressive supranuclear palsy (PSP). Cervós-Navarro J; Schumacher K J Neural Transm Suppl; 1994; 42():153-64. PubMed ID: 7964685 [TBL] [Abstract][Full Text] [Related]